EXAS vs IQST · rev $2.76B vs rev $207.0M
EXACT Sciences Corporation (EXAS) versus Iqstel Inc (IQST) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Iqstel Inc (IQST) is a telecom services company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported IQST revenue for 2026-06-30 was $207.0M. Net income was -$3.8M. IQST currently screens at market cap $6.5M.
EXAS currently screens at market cap $20.03B. IQST currently screens at market cap $6.5M.
Not investment advice. Open the EXAS and IQST stock pages for the full models.
Not investment advice.